Evidence map›Paper›PMID 41090763›Full record

ArticleCells2025

Mistletoe Extracts Inhibit Progressive Growth of Prostate Cancer Cells.

Sascha D Markowitsch, Larissa Albrecht, Moritz Meiborg, Jochen Rutz, Anita Thomas, Felix K-H Chun, Axel Haferkamp, Eva Juengel, Roman A Blaheta

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sascha D MarkowitschDepartment of Urology and Pediatric Urology, University Medical Center Mainz, 55131 Mainz, Germany.
Larissa AlbrechtDepartment of Urology and Pediatric Urology, University Medical Center Mainz, 55131 Mainz, Germany.
Moritz MeiborgDepartment of Urology, Goethe-University, 60590 Frankfurt am Main, Germany.
Jochen RutzDepartment of Urology and Pediatric Urology, University Medical Center Mainz, 55131 Mainz, Germany.
Anita ThomasDepartment of Urology and Pediatric Urology, University Medical Center Mainz, 55131 Mainz, Germany.
Felix K-H ChunDepartment of Urology, Goethe-University, 60590 Frankfurt am Main, Germany.
Axel HaferkampDepartment of Urology and Pediatric Urology, University Medical Center Mainz, 55131 Mainz, Germany.
Eva JuengelDepartment of Urology and Pediatric Urology, University Medical Center Mainz, 55131 Mainz, Germany.ORCID 0000-0002-6321-8707
Roman A BlahetaDepartment of Urology and Pediatric Urology, University Medical Center Mainz, 55131 Mainz, Germany.ORCID 0000-0002-0129-7972

Funding

Brigitta & Norbert Muth Stiftung, Wiesbaden, Germany N/ADr. Peter und Gabriele Strohmaier-Stiftung, Gütersloh, Germany N/AKönig-Baudouin-Stiftung & Familie Harald G. Müller Fonds, Brussels, Belgium N/AWALA Heilmittel GmbH, Bad Boll, Germany N/A
6 · The paper itself

Abstract

Although multimodal therapeutic management has significantly improved outcome in prostate cancer (PCa) patients, treatment options for castrate-resistant disease remain challenging. Plant-derived mistletoe extracts have supported cancer patients and are, therefore, widely used as complementary medicine. However, mechanisms behind possible mistletoe benefits to PCa patients remain to be explored. The present study was designed to evaluate the effect of mistletoe extracts from four different host trees (

Indexed as

MistletoePlant ExtractsProstatic NeoplasmsApoptosisCell CycleCell Line, TumorCell ProliferationHumansMalePlant Extractscell cyclinggrowthmistletoeproliferationprostate cancer

Identifiers

PMID41090763
PMCPMC12523822

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.